JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

The mesangium as a target for glomerulopathic light and heavy chains: pathogenic considerations in light and heavy chain-mediated glomerular damage.

Certain structurally abnormal light and heavy chains are known to be nephrotoxic and alter mesangial homeostasis producing pathological alterations. Many of the mechanisms involved in light chain-mesangial interactions have been deciphered using an in vitro model, providing a framework for understanding the sequence of events that leads to irreversible glomerular changes and eventually renal failure. The molecular events involved in the pathogenesis of these disorders are now for the most part well-established. These studies have delineated the sequence of steps involved and crucial events have been determined. An animal model is being developed which will undoubtedly contribute significantly to validate the information that has been obtained from the in vitro models. The present chapter will address the pathogenesis of these disorders with an emphasis on highlighting crucial steps possibly amenable to therapeutic intervention to stop or ameliorate adverse consequences leading to irreversible changes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app